hCDC4 gene mutations in endometrial cancer

Cancer Research

Volumn 62, Issue 16, 2002, Pages 4535-4539

  Spruck, Charles H ^a   Strohmaier, Heimo ^a   Sangfelt, Olle ^a   Müller, Hannes M ^b   Hubalek, Michael ^b   Müller Holzner, Elisabeth ^b   Marth, Christian ^b   Widschwendter, Martin ^b,c   Reed, Steven I ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN E;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CHROMOSOME 4Q; CONTROLLED STUDY; DNA REPLICATION; ENDOMETRIUM CANCER; GENE LOCATION; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PHASE TRANSITION; PRIORITY JOURNAL; PROTEIN DEGRADATION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; BLOTTING, NORTHERN; CELL CYCLE PROTEINS; CYCLIN E; ENDOMETRIAL NEOPLASMS; F-BOX PROTEINS; FEMALE; HELA CELLS; HUMANS; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UBIQUITIN-PROTEIN LIGASES;

EID: 0037102310     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Regulation of G(I) cyclin-dependent kinases in the mammalian cell cycle
2. Cyclin E in mid-cycle
3. Control of the GI/S transition
4. The role of cyclin E in the regulation of entry into S phase
5. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E
6. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line
7. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation
8. Archipelago regulates cyclin E levels in Drosophila and is mutated in human cancer cell lines
9. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase
10. Deregulation of the cell cycle in cancer
11. Deregulation of cyclin E in breast cancer
12. Cyclin E in human cancers
13. Expression of cyclin E and cyclin-dependent kinase 2 correlates with metastasis and prognosis in colorectal carcinoma
14. Prognostic implications of p27 and cyclin E protein contents in malignant lymphomas
15. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
16. High cyclin E and low p27/Kip1 expressions are potentially poor prognostic factors in lung adenocarcinoma patients
17. Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E
18. Deregulated cyclin E induces chromosome instability
19. DNA copy number losses in human neoplasms
20. SEL-10 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation
21. Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor
22. Expression of cell-cycle regulatory proteins in endometrial carcinomas: Correlations with hormone receptor status and clinicopathologic parameters
23. Hereditary cancer
24. Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells
25. Accumulation of cyclin E is not a prerequisite for passage through the restriction point